Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL. (Q54786879)

3 June 2018

title

Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL. (English)

1 reference

3 June 2018

11

Daniel Catovsky

1 reference

3 June 2018

10

Claire Dearden

1 reference

3 June 2018

9

Estella Matutes

1 reference

3 June 2018

5

Monica Else

1 reference

PubMed ID

19021053

3 June 2018

Vasantha Brito-Babapulle

7

Vasantha Brito Babapulle

1 reference

3 June 2018

Alison M. Morilla

1

Alison Morilla

1 reference

3 June 2018

Nnenna Osuji

4

Nnenna Osuji

1 reference

3 June 2018

Ilaria Del Giudice

3

Ilaria Del Giudice

1 reference

3 June 2018

Ricardo M. Morilla

6

Ricardo Morilla

1 reference

3 June 2018

author name string

David Gonzalez de Castro

2

1 reference

3 June 2018

Hannah Rudenko

8

1 reference

3 June 2018

Gareth J Morgan

12

1 reference

3 June 2018

publication date

1 November 2008

1 reference

3 June 2018

published in

Leukemia & Lymphoma

1 reference

3 June 2018

volume

49

1 reference

3 June 2018

issue

11

1 reference

3 June 2018

page(s)

2108-2115

1 reference

3 June 2018

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

ZAP-70 expression and prognosis in chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

Genomic aberrations and survival in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

IMGT, the international ImMunoGeneTics database

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

CD38 modifications in chronic lymphocytic leukemia: are they relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802360810

10.1080/10428190802360810

21 January 2018

Identifiers

DOI

1 reference

3 June 2018

PubMed ID

19021053

1 reference

3 June 2018